| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024739 |
| Receipt No. | R000023431 |
| Official scientific title of the study | The Significance of Continuous Sciatic Nerve Block to Continuous Femoral Nerve Block for Analgesia After High Tibial Osteotomy A Prospective, Randomized, Double-Blind Study |
| Date of disclosure of the study information | 2016/11/07 |
| Last modified on | 2016/11/07 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The Significance of Continuous Sciatic Nerve Block to Continuous Femoral Nerve Block for Analgesia After High Tibial Osteotomy
A Prospective, Randomized, Double-Blind Study |
|
| Title of the study (Brief title) | The Significance of Continuous Sciatic Nerve Block to Continuous Femoral Nerve Block for Analgesia After High Tibial Osteotomy
A Prospective, Randomized, Double-Blind Study |
|
| Region |
|
|
| Condition | ||
| Condition | Knee Osteoarthritis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the significance of sciatic nerve block to femoral nerve block after high tibial osteotomy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The number of IV PCA boluses |
| Key secondary outcomes | The number of patients accomplished the trial, postoperative visual analog scale score (VAS score) at rest and at motion, the distribution of pain, the time of initial IV PCA bolus, postoperative nausea and vomiting (PONV), postoperative motor and neurological impairment and total amount of opioid used intraoperatively. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | continuous femoral nerve block | |
| Interventions/Control_2 | continuous sciatic nerve block | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | unilateral HTO
ASA-PS 1 or 2 |
|||
| Key exclusion criteria | DM patient with neuropathy
neuromuscular disease vascular insufficiency of the lower limb cognitive dysfunction BMI over 35 renal impairment(eGFR under 60) liver dysfunction allergy to the drug used stomach ulcer pregnancy or lactation QTc over 0.44 enable to take the block position not appropriate for the study, dicision made by the doctor |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hamada Takako |
| Organization | Yokohama City University Hospital |
| Division name | Anesthesiology |
| Address | 3-9 Fukuura Kanazawa-ku Yokohama-city Kanagawa Pref. |
| TEL | 045-787-2800 |
| hamadatakako@hotmail.co.jp | |
| Public contact | |
| Name of contact person | Hamada Takako |
| Organization | Yokohama City University Hospital |
| Division name | Anesthesiology |
| Address | 3-9 Fukuura Kanazawa-ku Yokohama-city Kanagawa Pref. |
| TEL | 045-787-2800 |
| Homepage URL | |
| hamadatakako@hotmail.co.jp | |
| Sponsor | |
| Institute | Yokohama City University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023431 |